Literature DB >> 9365968

Haemodynamic responses to sevoflurane compared with halothane during inhalational induction in children.

C Kern1, T Erb, F J Frei.   

Abstract

We studied the haemodynamic changes during induction of anaesthesia in 50 ASA I and II children (1-12 yrs) undergoing minor elective surgery. The patients were randomly divided into two groups to receive either halothane (n = 25) or sevoflurane (n = 25) in a mixture of O2 and N2O (40:60) for mask induction of anaesthesia. Induction of anaesthesia was performed with an overpressure technique by administering rapid increases of gas concentrations, in increments of 1% up to 7% for sevoflurane and of 0.5% up to 3% for halothane. Induction was smooth and rapid in both groups but characterized by increases in heart rate and systolic blood pressure up to 20% especially in the sevoflurane group (P < 0.05); these increases in the latter group were significant compared with baseline and the halothane group (P < 0.05). No serious complications were observed. The authors conclude that more children experienced heart rate and blood pressure increases during the early stage of inhalational induction with sevoflurane compared with halothane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365968     DOI: 10.1046/j.1460-9592.1997.d01-124.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  3 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 2.  [Inhalation and intravenous anesthesia in pediatric patients].

Authors:  M Jöhr
Journal:  Anaesthesist       Date:  2016-06       Impact factor: 1.041

3.  The relationship between expired concentration of sevoflurane and sympathovagal tone in children.

Authors:  Eric Wodey; Lotfi Senhadji; Patrick Pladys; François Carre; Claude Ecoffey
Journal:  Anesth Analg       Date:  2003-08       Impact factor: 6.627

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.